tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lisata Therapeutics: Promising Pipeline and Strong Financials Support Buy Rating
PremiumRatingsLisata Therapeutics: Promising Pipeline and Strong Financials Support Buy Rating
2M ago
Lisata Therapeutics’ Earnings Call Highlights Strategic Growth
Premium
Company Announcements
Lisata Therapeutics’ Earnings Call Highlights Strategic Growth
2M ago
Lisata Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Lisata Therapeutics Reports Q2 2025 Financial Results
2M ago
Lisata Therapeutics price target raised to $32 from $20 at Brookline
PremiumThe FlyLisata Therapeutics price target raised to $32 from $20 at Brookline
3M ago
Lisata Therapeutics Secures U.S. Patent for Certepetide
Premium
Company Announcements
Lisata Therapeutics Secures U.S. Patent for Certepetide
3M ago
Lisata Therapeutics Reveals Promising Phase 2 Trial Data
Premium
Company Announcements
Lisata Therapeutics Reveals Promising Phase 2 Trial Data
4M ago
Lisata Therapeutics Amends Executive Employment Agreements
PremiumCompany AnnouncementsLisata Therapeutics Amends Executive Employment Agreements
4M ago
Lisata Therapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Lisata Therapeutics Approves Key Proposals at Annual Meeting
4M ago
Lisata Therapeutics’ Earnings Call Highlights Progress
Premium
Company Announcements
Lisata Therapeutics’ Earnings Call Highlights Progress
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100